PROM1 and hepatocellular carcinoma: A difference in treatment results of IFN-γ was investigated in different HCC cell lines: a high percentage of CD133+ cells (Huh7 and PLC8024) were more resistant to IFN-γ treatment than HCC cell lines with a low percentage of CD133+ cells122.